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Unilateral progressive osseous heteroplasia
A 50-year-old male patient presented with firm subcutaneous nodules
and plaques with a gritty texture, unilaterally affecting the left side of
the trunk and the left limbs. These lesions had had a progressive
course since early childhood and caused functional impairment.
There was no family history of similar disorders. No phospho-
calcium metabolism abnormalities were observed. Biopsies of the
affected areas demonstrated osteoma cutis. Analysis of DNA showed
no mutation of the GNAS gene. The clinical features were consistent
with progressive osseous heteroplasia, atypically presented in a unilat-
eral form, probably revealing a mosaic distribution.
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P rogressive osseous heteroplasia (POH) is a distinctdisorder of mesenchymal differentiation, describedby Kaplan in 1994 in children initially thought to
have atypical progressive fibrodysplasia ossificans [1]. It
may either be sporadic or inherited as an autosomal domi-
nant trait [1]. POH is characterized by dermal ossification
during childhood with progressive heterotopic ossification
of cutaneous, subcutaneous and deep connective tissues [1,
2]. Fewer than 60 cases have been identified worldwide [3].
Recently, Shore et al. reported that paternally inherited,
inactivating mutations in the GNAS gene are implicated
in the pathogenesis of POH [4]. GNAS encodes for the
alpha subunit of the stimulatory G protein of adenylyl
cyclase and is thought to be a critical negative regulator
of osteogenesis in non-osseous connective tissues, espe-
cially in skin, fat, and skeletal muscle [4, 5].
Case report
A 50-year-old male patient was observed with subcutane-
ous nodules and plaques which had been noticed since
infancy, below the age of 1. These lesions had progres-
sively expanded in number and size. On examination they
were firm, relatively well-demarcated, skin-coloured or
slightly blue, with a gritty texture. Only the left side of
the body was affected, predominantly the scapular region,
arm, forearm, digits I-III, thigh, leg, dorsal aspect of the
foot and heel (figure 1). The patient complained of func-
tional impairment in the tibio-tarsic joint. No acute flares
of the disease were reported, nor exacerbation with trauma
or intramuscular injections.
He was otherwise healthy, mentally normal and attended
normal school. There was no family history of skeletal
disorders, nor were the parents consanguineous. He had
no facial dysmorphism, nor musculoskeletal deformities.
The patient was of normal weight and height. Serum and
urine levels of calcium and phosphate were normal, as
were those of parathyroid and thyroid hormones and vita-
min D metabolites. Lactate dehydrogenase and alkaline
phosphatase levels were also within the normal ranges.
A skin biopsy revealed islands of well-differentiated bone
in the reticular dermis, typical of osteoma cutis (figure 2).
Skeletal radiological imaging of the affected areas showed
extensive ossification involving the subcutaneous and
deep tissues and pronounced at the ankle with continuity
within the muscular plane (figure 3). Genomic DNA was
extracted from peripheral blood samples and subsequent
analysis showed no mutations in the gene encoding for the
alpha subunit of the stimulatory G protein of adenylyl
cyclase (GNAS).
The final diagnosis was unilateral POH, based on clinical
features, clinical evolution, normal phospho-calcium
metabolism, skin biopsy findings and radiological imaging.
Discussion
This case report corresponds to a rare ossifying disorder
with few other cases previously reported, particularly if
we take into account that it exists in a sporadic and uni-
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Figure 1. A, B) Subcutaneous nodules and plaques along the
left forearm and leg.
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lateral form in a male patient [6-10]. Furthermore, the
absence of mutation in the protein coding region of the
GNAS gene is a relevant event. However, this mutation
seems to be present in only 64% of POH patients, as
found in a recent study [5]. It is interesting to note that
individuals without detectable mutations were clinically
indistinguishable from those with mutations. The occur-
rence of mutations in a regulatory region of the GNAS
gene, or in another gene, is probable in those cases but
has never been reported until now.
Not only most cases of POH, but also plate-like osteoma
cutis and Albright’s hereditary osteodystrophy (AHO),
can result from heterozygous inactivating germ-line muta-
tions of GNAS localized to 20q13, causing abnormal
expression or function of the alpha subunit of the stimula-
tory G protein of adenylyl cyclase [4]. GNAS-alpha is
imprinted in a tissue-specific manner: maternal inheri-
tance of a mutation in GNAS leads to an AHO phenotype
with hormonal resistance, whereas paternal inheritance
leads to AHO phenotype without hormonal resistance or
POH [4, 11, 12]. However, the mechanism by which a
mutation in the paternally derived GNAS gene results in
heterotopic ossification originating in the fat cells, which
would seem to require the conversion of fat cells to osteo-
blasts, remains unknown [12]. GNAS somatic (postzygo-
tic) activating mutations play a role in another skeletal
disease: the McCune-Albright syndrome [12].
The asymmetric mosaic distribution of lesions is an impor-
tant feature of POH and some unilateral cases have already
been reported [1, 7, 8]. The anatomical distribution of
lesions suggests that the pathogenesis may involve a vari-
able expression of the mutant gene in mesenchymal stem
cells destined for widespread mosaic distribution [1, 2]. In
addition to the highly variable phenotypic expression pres-
ent in POH, non-penetrance cases have also been observed
in some families. These could be due to epigenetic modifi-
cations, complex regulatory mechanisms, influences from
other genetic loci, or environmental factors [4]. Many ques-
tions about the genotypic complexity and phenotypic vari-
ability in POH are waiting for answers, however studies are
being conducted to complete the puzzle.
Finally, to our knowledge, this is the first case of unilat-
eral POH reported in Portugal, even though a case of het-
erotopic cutaneous ossification in a 12-month-old child
was described in 2006 [13]. ■
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Figure 3. A, B) Radiographs showing extensive ossification
of the forearm, hand and left leg. Right leg with no lesions.
Figure 2. Skin biopsy compatible with osteoma cutis. Hae-
matoxylin and Eosin stain; original magnification × 40.
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